2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone

Catalog No. :
ACBRFP968
CAS No. :
2101208-44-8
Molecular Formula :
C34H44N6O6
Molecular Weight :
632.76

IUPAC Name:2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone

2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$865.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone
IUPAC Name2,7-bis(3-morpholinopropyl)-4-((2-(pyrrolidin-1-yl)ethyl)amino)benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetraone
Molecular FormulaC34H44N6O6
Molecular Weight632.76
SMILESO=C1C2=C3C(=CC(NCCN4CCCC4)=C4C(=O)N(CCCN5CCOCC5)C(=O)C(=C43)C=C2)C(=O)N1CCCN1CCOCC1
InChI KeyKCCGFZWBVFNFGW-UHFFFAOYSA-N
SynonymCM03 (G-quadruplex binder CM03);CM03;Benzo[lmn][3,8]phenanthroline-1,3,6,8(2H,7H)-tetrone, 2,7-bis[3-(4-morpholinyl)propyl]-4-[[2-(1-pyrrolidinyl)ethyl]amino]-
CAS No.2101208-44-8

Synthetic Route by SureRoute

1. ACBRFP968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBRFP968 route product structure diagram
    ACBRFP9682101208-44-8
Inquiry

2. ACBRFP968 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLNJO267 route compound structure diagram
    ACLNJO2674441-30-9 In Stock
  4. Then
  5. ACBRFP968 route product structure diagram
    ACBRFP9682101208-44-8
Inquiry

Comments (0)